Randomized Controlled Trial
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Jun 27, 2025; 17(6): 106069
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.106069
Table 1 Baseline characteristics of patients and resected lesions, n (%)

Experimental group (n = 44)
Control group (n = 46)
P value
Age [M, (Q1, Q3), years]56.5 (49.0, 64.5)58.5 (49.0, 62.0)0.994
Sex0.411
    Male21 (47.73)18 (39.13)
    Female23 (52.27)28 (60.87)
Maximum lesion diameter [M, (Q1, Q3), mm]29.5 (20.0, 39.0)29.5 (20.0, 48.0)0.474
Lesion location0.296
    Fundus of stomach18 (40.90)26 (56.52)
    Gastric body23 (52.27)18 (39.13)
    Antrum of stomach3 (6.82)2 (4.35)
Level of origin of lesion0.072
    Not reaching muscularis propria3 (6.82)0 (0)
    Muscularis propria41 (93.18)46 (100)
Growth pattern0.875
    Intraluminal growth3 (6.82)3 (6.52)
    Extraluminal growth2 (4.54)1 (2.17)
Intraluminal and extraluminal growth39 (88.64)42 (91.30)
Pathological type0.634
    Stromal tumor25 (56.82)33 (71.74)
    Leiomyoma10 (22.73)6 (13.04)
    Ectopia pancreas2 (4.54)1 (2.17)
    Neurofibroma3 (6.82)2 (4.35)
    Other3 (6.82)4 (8.70)